Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01179230 · ClinicalTrials.gov registry record

Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT

A clinical trial, sponsored by Hartford Hospital.

Completed
Registry status
136
Enrollment target

NCT01179230 is a clinical trial that has completed, run by Hartford Hospital. The registered enrollment target is 136 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01179230 has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
136 participants
Enrollment target

Study Summary

Many stress tests being done today have two parts, the stress test and the pictures of your heart. The investigators are comparing a newer technique to obtain the pictures (PET imaging) to the standard method (SPECT imaging). However, it is not known if the new test is better than the old test. It is important to have a standard to compare these tests to, and that is why people who will be getting a cardiac catheterization are being asked to participate. The information about your arteries from the cardiac catheterization will be used to judge which stress test is better. The investigators hypothesize that the newer method (PET imaging) will be more accurate than the old method (SPECT) in detecting heart disease.

Interventions

  • OTHER SPECT imaging
  • OTHER PET imaging

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2005-01
Est. Completion 2012-12

Sponsor

Hartford Hospital

75 total trials

What the Registry Record Tells You About NCT01179230

The ClinicalTrials.gov registry entry for NCT01179230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which SPECT imaging is the first listed.

NCT01179230 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01179230 about?

NCT01179230 is a clinical study titled "Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT". Many stress tests being done today have two parts, the stress test and the pictures of your heart. The investigators are comparing a newer technique to obtain the pictures (PET imaging) to the standard method (SPECT imaging). However, it is not known if the new test is better than the old test. It i...

What is the current status of trial NCT01179230?

This trial is currently completed. The enrollment target is 136 participants. The study started on 2005-01. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01179230?

The interventions under investigation include: SPECT imaging (OTHER), PET imaging (OTHER).

Who is sponsoring clinical trial NCT01179230?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.